These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15648179)

  • 1. Lifestyle and medical approaches to cancer prevention.
    Greenwald P
    Recent Results Cancer Res; 2005; 166():1-15. PubMed ID: 15648179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
    Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer prevention clinical trials.
    Greenwald P
    J Clin Oncol; 2002 Sep; 20(18 Suppl):14S-22S. PubMed ID: 12235220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From carcinogenesis to clinical interventions for cancer prevention.
    Greenwald P
    Toxicology; 2001 Sep; 166(1-2):37-45. PubMed ID: 11518609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer.
    Kelloff GJ; Lieberman R; Steele VE; Boone CW; Lubet RA; Kopelovich L; Malone WA; Crowell JA; Higley HR; Sigman CC
    Urology; 2001 Apr; 57(4 Suppl 1):46-51. PubMed ID: 11295594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
    Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
    Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of cancer.
    Tsao AS; Kim ES; Hong WK
    CA Cancer J Clin; 2004; 54(3):150-80. PubMed ID: 15195789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.
    Harris RE
    Inflammopharmacology; 2009 Apr; 17(2):55-67. PubMed ID: 19340409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing cancer: dietary lifestyle or clinical intervention?
    Young GP; Le Leu RK
    Asia Pac J Clin Nutr; 2002; 11 Suppl 3():S618-31. PubMed ID: 12492655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.
    Lieberman R
    Urology; 2001 Apr; 57(4 Suppl 1):224-9. PubMed ID: 11295633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
    Fujimoto N; Chang C; Nomura M; Matsumoto T
    Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications.
    Chhabra G; Singh CK; Ndiaye MA; Fedorowicz S; Molot A; Ahmad N
    Cancer Lett; 2018 May; 422():9-18. PubMed ID: 29471004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of prostate cancer through custom tailoring of chemopreventive regimen.
    Siddiqui IA; Afaq F; Adhami VM; Mukhtar H
    Chem Biol Interact; 2008 Jan; 171(2):122-32. PubMed ID: 17403520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introductory remarks: development of chemopreventive agents for prostate cancer.
    Kelloff GJ; Boone CW; Malone WF; Steele VE; Doody LA
    J Cell Biochem Suppl; 1992; 16H():1-8. PubMed ID: 1289663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target populations and strategies for chemoprevention trials of prostate cancer.
    Bostwick DG
    J Cell Biochem Suppl; 1994; 19():191-6. PubMed ID: 7823591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
    Lippman SM; Lee JJ
    Cancer Res; 2006 Mar; 66(6):2893-903. PubMed ID: 16540634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer prevention: agent development strategies.
    Parnes HL; House MG; Tangrea JA
    Recent Results Cancer Res; 2014; 202():121-31. PubMed ID: 24531786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of prostate cancer by major dietary phytochemicals.
    Bommareddy A; Eggleston W; Prelewicz S; Antal A; Witczak Z; McCune DF; Vanwert AL
    Anticancer Res; 2013 Oct; 33(10):4163-74. PubMed ID: 24122979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention research: implications for primary care practice.
    Denicoff AM; Padberg RM
    Lippincotts Prim Care Pract; 2000; 4(4):410-6. PubMed ID: 11261117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.